Dexcom issues correction for G6 software
By HME News Staff
Updated 10:09 AM CST, Mon January 5, 2026
WASHINGTON – Dexcom has issued a correction for Dexcom G6 and G6 Pro Software due to an identified bug that can cause the app to terminate unexpectedly, according to the U.S. Food and Drug Administration (FDA). As a result of the bug, the user may not receive estimated glucose values, alarms or alerts. If a user is unaware that the app has terminated, there is potential for missed detection of a high blood sugar (hyperglycemic) or low blood sugar (hypoglycemic) event. The correction only affects users of v.1.15.0 of the Android US App and does not apply to other users. All affected devices have been updated to resolve this issue, and the FDA advises users to upgrade from app version 1.15.0 as soon as possible. Dexcom recently announced it will stop making the G6 Continuous Glucose Monitoring (CGM) System on July 1, 2026. The company launched the G7 15 Day CGM System on Dec. 1.
Comments